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Abstract
Uptake of weak acid and weak base chemotherapeutic
drugs by tumors is greatly influenced by the tumor
extracellular / interstitial pH (pHe), the intracellular pH
(pHi ) maintained by the tumor cells, and by the
ionization properties of the drug itself. The acid-outside
plasmalemmal pH gradient in tumors acts to exclude
weak base drugs like the anthracyclines, anthraqui-
nones, and vinca alkaloids from the cells, leading to a
substantial degree of ‘‘physiological drug resistance’’ in
tumors. We have induced acute metabolic alkalosis in
C3H tumor-bearing C3H/hen mice, by gavage and by
intraperitoneal ( i.p. ) administration of NaHCO3.
31P
magnetic resonance spectroscopic measurements of
3-aminopropylphosphonate show increases of up to 0.6
pH units in tumor pHe, and 0.2 to 0.3 pH units in hind leg
tissue pHe, within 2 hours of i.p. administration of
NaHCO3. Theoretical calculations of mitoxantrone up-
take into tumor and normal (hind leg) tissue at the
measured pHe and pHi values indicate that a gain in
therapeutic index of up to 3.3- fold is possible with
NaHCO3 pretreatment. Treatment of C3H tumor-bearing
mice with 12 mg/kg mitoxantrone resulted in a tumor
growth delay of 9 days, whereas combined NaHCO3–
mitoxantrone therapy resulted in an enhancement of the
TGD to 16 days. Neoplasia (2001) 3, 227–235.
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Introduction
The extracellular pH (pHe) and intracellular pH (pHi ) of
tumors influence the effectiveness of chemotherapy by
influencing drug uptake kinetics and the ionic equilibrium of
weak acid and weak base drug molecules. Weak base
drug molecules like mitoxantrone will tend to be retained in
the more acidic compartments within a tumor, whereas
weak acid species like chlorambucil will tend to concentrate
in the more alkaline compartments [1,2 ]. Electrode
measurements in humans and animals reveal tumor
extracellular / interstitial pH to be generally lower than the
pH of normal tissue [3], but pooled measurements of pH of
normal and tumor tissue made by various investigators
show some overlap [4]. In a recent review, Gerweck [4]
has argued that this apparent overlap results from differ-
ences in technical variables associated with electrode
measurements of tissue pH by different investigators, as
well as physiological and metabolic differences between
patients at the time of examination, and has resulted in an
underexploitation of the pH difference between normal and
tumor tissue for therapeutic purposes. Noninvasive 31P
magnetic resonance spectroscopy (MRS) allows the
simultaneous investigation of tissue pHi from the chemical
shift of inorganic phosphate (Pi ) [5 ] and pHe from the
chemical shift of an extracellular pH probe such as 3-
aminopropylphosphonate (3-APP) [6]. MRS measure-
ments of tumor pHi and pHe in various human tumor
xenografts in mice indicate that tumor pHi is similar to or
more alkaline than in normal tissue, whereas tumor pHe is
more acidic than in normal tissues [7,8 ], leading to an
acid-outside plasmalemmal pH gradient in tumors.
We have recently demonstrated that this acid-outside
plasmalemmal pH gradient can be abolished, even reversed,
in experimental tumor xenografts by chronic ad libitum
administration of 200 mM sodium bicarbonate to the host
mice [9]. Further, we have demonstrated that the antitumor
activity of doxorubicin in an SCID mouse model of MCF-7
human breast carcinoma is enhanced by NaHCO3- induced
tumor alkalinization [9]. Chronic administration of NaHCO3 to
mice is undesirable due to potential hypernatremia and other
metabolic disorders, and is also not translatable to humans.
We have investigated the feasibility of inducing acute
alkalinization of tumors in a C3H mouse model by i.p. and
gavage administration of NaHCO3 to the host animals. We
have also measured tumor and normal tissue pHe and pHi in
mice after oral administration of NH4Cl to the host animals to
induce acidosis. The influence of acute alkalinization of
tumors on tumor response to a weak base drug, mitoxan-
trone, has been investigated. Mitoxantrone was chosen over
doxorubicin because of its greater octanol–water partition
coefficient, and because of its dual positive ionization status
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at physiological pH compared to the singly charged
doxorubicin.
Materials and Methods
Cells and Animals Used
C3H murine mammary carcinoma tumor fragments were
implanted in the mammary fat pads of 5- to 6-week-old
female C3H/Hen mice by means of a 12G trocar. Tumor
volumes were calculated from orthogonal measurements of
external dimensions as (width)2( length) /2. MRS was
performed on the mice once the tumors had grown
to > 300 mm3.
Gavage Administration of NaHCO3/NH4Cl
To induce acute metabolic acidosis or alkalosis by the oral
route, mice were administered either 0.7 ml 1 M NH4Cl or 0.7
ml 1 M NaHCO3, respectively, by gavage. Anesthetization
immediately following NH4Cl gavage resulted in the deaths
of all three mice tested. For this reason, for MRS measure-
ments of mice that had been administered either NH4Cl or
NaHCO3 by gavage, mice were anesthetized 2 hours
following gavage. Control and NaHCO3-treated mice were
anesthetized using a mix of Ketamine, Xylazine and
Acepromazine (72/6/6 mg/kg), whereas mice that had
been administered NH4Cl by gavage were anesthetized with
75% of this dose, due to reduced tolerance of these mice to
one or more of the components even 2 hours after the
gavage. NH4Cl - and NaHCO3-treated mice were denied
access to normal ad libitum water for 2 hours following
gavage, at which point they were anesthetized and prepared
for 31P MRS of either tumor or hind leg tissue. pH measure-
ments were also made on untreated control mice for
comparison. Despite the reduced dose of anesthetic, the
duration of anesthesia and recovery time were greater in
NH4Cl- treated mice than in control mice that had been given
the full anesthetic dose. Recovery from anesthesia was also
somewhat prolonged in NaHCO3- treated mice compared
with control mice.
Intraperitoneal Administration of NaHCO3
For experiments involving i.p. administration of NaHCO3,
mice were anesthetized as described earlier and adminis-
tered 3-APP ( i.p., 0.4 ml0.24 M, pH 7.4 at room
temperature). A 3/4- in., 24G catheter (Elf Sanofi Inc.,
Overland Park, KS), connected through a three-way valve
to two 60-cm- long, 1.58-mm-ID polyethylene tubes
(Becton Dickinson, Parsippany, NJ), was then inserted into
the i.p. cavity of the anesthetized mouse. This set-up
permitted delivery of NaHCO3 (0.7 ml1 M) at the
appropriate time, or delivery of a ‘‘booster’’ dose of 3-
APP (0.2 ml0.24 M, if required) without moving the animal
out of the magnet. The combined dead volume of the i.p.
catheter and three-way valve was 0.2 ml, meaning that
delivery of a booster dose of 3-APP resulted in the delivery
of an additional 0.2 ml of NaHCO3 as well. The mouse was
immobilized on a home-built MRS solenoid coil and
centered in the magnet. NaHCO3 was tolerated by
anesthetized and alert C3H mice up to the maximum tested
dose of 1 ml1 M. It was found that i.p. NaHCO3 enhanced
the duration of the anesthesia and also increased the
recovery time of C3H mice. Intraperitoneal administration of
NH4Cl was not tolerated by anesthetized mice, although
alert mice tolerated up to 1 ml1 M NH4Cl without any
fatalities (n=4).
Localized In Vivo 31P MR Spectroscopy
All in vivo measurements were performed at 4.7 T on a
Bruker Biospec spectrometer / imager equipped with a 14
G/cm self -shielded gradient insert, using home-built
solenoid coils of suitable diameter. Image-guided vol-
ume-selective 31P MR spectra of tumors or hind leg tissue
in anesthetized mice were acquired using the PRESS
sequence [10]. pHe and pHi were measured from the
chemical shifts of exogenous 3-APP and endogenous Pi,
respectively, as described earlier [8 ]. For spectroscopy of
tumors, 0.4 ml of 0.24 M 3-APP was administered i.p. to
anesthetized mice just before their immobilization on the
MRS coil. This procedure did not result in sufficient loading
of hind leg (mostly muscle) tissue with 3-APP. Hence, for
spectroscopy of hind legs, 0.6 ml of 0.24 M 3-APP was
administered ( i.p. ) to alert mice 2 hours before anesthe-
tization. Immediately following anesthetization, a further 0.4
ml of 3-APP was injected ( i.p. ) and the mouse prepared
for 31P MRS as before. This procedure resulted in usably
high 3-APP signals in the 31P MR spectra of 16 of 19 mice
tested.
Chemotherapy
Two groups of 6-week-old female C3H/Hen mice
(n=4, each) bearing C3H tumors in the mammary fat
pad (approximately 250 mm3) were used. One group was
administered a single dose of 0.7 ml1 M NaHCO3 ( i.p. )
and denied access to drinking water for the next 4 hours,
whereas the other group did not receive any treatment and
had uninterrupted access to ad libitum water. The two
groups were compared for changes in tumor growth rates
to assess the influence of NaHCO3 on tumor growth. In a
separate experiment, four groups of C3H/Hen mice (n=4,
each) bearing C3H tumors in the mammary fat pad were
used. Groups A and B were administered two doses of
mitoxantrone ( i.v., 6 mg/kg) given 7 days apart, whereas
groups C and D were administered a single dose of
mitoxantrone ( i.v., 12 mg/kg). Groups B and D were also
administered 0.7 ml1 M NaHCO3 ( i.p. ) 2 hours before
each mitoxantrone injection. NaHCO3- treated mice were
denied access to ad libitum water for 4 hours starting with
administration of the NaHCO3, but were allowed continu-
ous access to solid food. Access to drinking water was
restored 2 hours after drug administration. The toxicity of
mitoxantrone to mice has been reported to have a marked
circadian dependence, with the lowest toxicity being
observed at 11 to 15 hours after light onset [11]. For this
reason, mitoxantrone was administered 12 hours after light
onset in all experiments.
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Results
31P MR spectra of tumor and (normal ) hind leg tissue were
acquired before and immediately following i.p. administration
of NaHCO3 to anesthetized mice placed in the magnet.
Chemical shifts were calibrated against the  -NTP reso-
nance, which was set to 10.05 ppm in all spectra. Tissue
pHe and pHi were calculated from the chemical shifts of 3-
APP and Pi, respectively, as explained elsewhere [8]. The
3-APP resonance shifts upfield ( to lower parts per million
(ppm) values) on the 31P MR spectrum with increasing pH,
whereas the opposite is true of the Pi resonance. Figure 1
shows a series of 31P MR spectra obtained from a C3H tumor
before and following NaHCO3 administration. A slow shift
over 2 hours of the Pi resonance to higher chemical shifts is
visible, indicating an alkalinization of tumor pHi. It can also be
seen that the 3-APP resonance shifts to lower chemical
shifts, indicating an alkalinization of tumor pHe. The 3-APP
resonance tended to broaden immediately following
NaHCO3 administration. This indicates a greater hetero-
geneity of tumor pHe induced by NaHCO3 administration,
and suggests the presence of compartments within the
tumor exhibiting differing kinetics of alkalinization in
response to the NaHCO3. The intensities of the NTP
resonances, an indicator of the energetic status of the
tumors, were not significantly altered by the NaHCO3
administration. The significant increase in the phosphocrea-
tine resonance seen in Figure 1 was not consistently
observed in all tumors. The pHi and pHe corresponding to
these spectra are plotted in Figure 3B.
Figure 2 shows a series of 31P MR spectra acquired from
the normal hind leg tissue of a tumor-bearing C3H mouse. A
shift of the 3-APP peak to lower ppm values is visible 45
minutes after i.p. delivery of NaHCO3 to themouse, indicating
an increase in tissue pHe that persists through 2 hours
postinjection. A small shift of the Pi peak to higher ppm values
is also visible by 45 minutes postinjection, indicating an
increase in tissue pHi. Significant changes in the NTP peaks
or in the large phosphocreatine peak (2.5 ppm) were not
observed subsequent to the NaHCO3 injection. The pHe and
pHi values corresponding to this experiment are plotted in the
inset in Figure 2. It can be seen that NaHCO3 administration
produces a small but persistent alkalinization of both pHe and
pHi in hind leg tissue through at least 2 hours postinjection.
Panels B to D of Figure 3 depict pHe and pHi changes in
response to i.p. administration of NaHCO3 in large C3H
tumors, whereas panel A depicts the pH response of a
smaller tumor. It can be seen from Figure 3A that both pHe
and pHi in this smaller C3H tumor are neutral to alkaline, and
do not increase further upon i.p. administration of NaHCO3.
As seen in Figure 3B  D, resting pHe in large C3H tumors
ranges from 6.1 to 6.7, and inversely corresponds to tumor
size. It can also be seen that pHe in these acidic tumors
increases in response to i.p. administration of NaHCO3.
Resting pHi in the tumors shown in Figure 3B  D , was
neutral to acidic (6.75 to 7.05), and increased in response to
NaHCO3 administration. Unlike the 3-APP resonance, which
is purely extracellular in origin, the Pi resonance includes the
contributions of both extracellular and intracellular Pi. As
Figure 1. A series of 31P MR spectra were obtained from a 975 -mm3 C3H tumor before and after i.p. administration of 0.7 ml1 M NaHCO3 to the mouse at t =0
minutes. Chemical shifts are calibrated against the  -NTP resonance, which is set to 10.05 ppm. By 1 hour postinjection, the pHe of the tumor is substantially
raised, as indicated by the shift of the 3 -APP resonance upfield to lower ppm values, and this increase persists through 4 hours postinjection. Tumor pHi is increased
to a small extent by 4 hours postinjection as well, as indicated by the shift to higher ppm values of the Pi resonance.
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such, the increase in pH reported by the Pi resonance is
partly due to the extracellular alkalinization reported inde-
pendently by the 3-APP resonance. The increases in pH
indicated by the Pi resonance in these tumors following
NaHCO3 administration is thus an overestimate of any
increases in tumor pHi.
pHe and pHi of C3H tumors were also measured in mice
that had been administered either NaHCO3 or NH4Cl by
gavage, as well as in control mice, as explained earlier. To
further investigate a possible relationship between tumor
size and tumor pHe (Figure 3 ), tumors from mice in the
control group are presented in three size categories in Figure
4. pH values for tumors in all groups of mice were analyzed
by the Student’s t test or by ANOVA. Although there is a
downward trend to the mean, neither pHe nor pHi was
statistically significantly affected by tumor size for tumors in
the control group, for the tumor size ranges shown in Figure
4 (P > .2). Three hours after NaHCO3 administration by
Figure 2. A series of 31P MR spectra were obtained from the hind leg of a C3H /Hen mouse before and after i.p. administration of 0.7 ml1 M NaHCO3 to the mouse
at t =0 minutes. Signal intensities of both the 3 -APP and Pi peaks were low compared with spectra obtained from tumors. A small shift of the 3 -APP peak to lower
ppm values is visible by 45 minutes postinjection, indicating alkalinization of tissue pHe. A small shift of the Pi resonance to higher ppm values is also visible,
indicating alkalinization of pHi. The intensities of the phosphocreatine peak (2.5 ppm) and the NTP peaks 5, 10.05, and 18.5 ppm) did not change
significantly during the course of MRS experiment. The inset shows the calculated pHe and pHi versus time in hind leg tissue from these spectra. Both pHe and pHi
are seen to increase slightly following i.p. administration of 0.7 ml1 M NaHCO3.
Figure 3. pHe and pHi versus time in C3H tumors from four different animals that were administered 0.7 ml1 M NaHCO3 ( i.p. ) at t =0 minutes. The larger tumors in
panels B to D can be seen to have more acidic pHe and pHi before NaHCO3 administration than the smaller tumor shown in panel A. The more acidic tumors in B to D
show increases of both pHe and pHi by 2 hours postinjection of the NaHCO3, whereas the neutral tumor in A did not alkalinize in response to the NaHCO3 bolus.
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gavage, tumor pHi in NaHCO3-treated mice was not
significantly different from tumor pHi in control animals
(P > .05 against tumors in all three control groups). How-
ever, tumor pHe was significantly higher in NaHCO3-treated
mice compared to tumors in untreated control mice in the two
larger size categories (P < .05). Tumor pHe in NaHCO3-
treated mice was marginally higher than tumor pHe in the
smallest group of tumors (688±211 mm3) in control mice
(P =.06). Both tumor pHi and tumor pHe were significantly
lower in NH4Cl- treated mice than in control mice regardless
of tumor size (P < .03 in all cases).
pHe and pHi of normal hind leg tissue were measured in
mice 3 hours after they were treated by gavage admin-
istration of either NaHCO3 or NH4Cl, and in control mice
(Figure 5 ). pH values for the three groups were analyzed by
the Student’s t test. Gavage administration of NaHCO3 to
mice did not significantly affect pHi (P =.17) or pHe (P =.5)
of hind leg tissue compared to control animals. However,
gavage administration of NH4Cl to mice did significantly
lower both pHe (P =.003) as well as pHi (P =.04) compared
with control animals.
We have previously mathematically modeled the parti-
tioning of singly charged weak base and weak acid drugs into
cells at various pHi and pHe [12]. For a doubly charged weak
base drug molecule M, the following equilibria are expected




MHþ  !K2 MþHþ
Actually, there will be two distinct singly charged intermedi-
ates MH+ in the above equilibrium, depending on which
proton on MH2
2+ comes off first. But the relevant protons are
symmetrically located on mitoxantrone, and we have there-
fore shown both singly charged species as being identical in
the above chemical equations. This simplification is justifi-
able in our situation because, at physiological pH, a drug with
pKa1 of 8.25 (such as mitoxantrone) exists mostly in the
charged forms, and the expression for intracellular - to-
extracellular drug ratio (Equation 1, below) is insensitive to
the value of the acid dissociation constants for the two singly
charged species. Making the assumption that the cell
membrane is essentially impermeable to the charged
species MH+ and MH2
2+ , and that there is a fast equilibra-
tion of the uncharged species across the cell membrane
[12], we can compute the following relationship for the
intracellular - to-extracellular ratio of total drug:
M½ iþ MHþ½ iþ MH2þ2
 
i




pK2pHið Þ þ 10 pK1þpK22pHið Þ
1þ 10 pK2pHeð Þ þ 10 pK1þpK22pHeð Þ
ð1Þ
Figure 4. Average pHe and pHi values ( ±SD ) from C3H tumors in control
mice, and in mice that were administered either NaHCO3 or NH4Cl ( 0.7 ml1
M) by gavage. Tumors from control mice were separated into three categories
based on size. Neither pHe nor pHi was significantly affected by tumor size for
tumors in the control group (P > .2 ). Tumor pHi in NaHCO3 - treated mice was
not significantly different from tumor pHi in control animals (P > .05 against
tumors in all three control groups ). #Tumor pHe was significantly higher in
NaHCO3 - treated mice compared to tumors in untreated control mice in the
two larger size categories (P < .05 ). Tumor pHe in NaHCO3 - treated mice was
marginally higher than tumor pHe in the smallest group of tumors ( 688±211
mm3) in control mice (P = .06 ). *Both tumor pHi and tumor pHe were
significantly lower in NH4Cl - treated mice than in control mice regardless of
tumor size (P < .03 in all cases ).
Figure 5. Average pHe and pHi values ( ±SD) from normal hind leg tissue in
control mice, and in mice that were administered either NaHCO3 or NH4Cl (0.7
ml1 M) by gavage. Gavage administration of NaHCO3 did not result in
significant changes in either pHe (P= .5 ) or pHi (P= .17 ). *Gavage admin-
istration of NH4Cl resulted in a considerable drop in pHe (P= .003 ) as well as
pHi (P= .04 ) of hind leg tissue in treated mice compared with control mice.
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Analogous calculations can be performed for a singly
charged weak acid drug AH, for which the following
equilibrium can be expected:
AH !Ka A þHþ
and the following relationship can be derived for the
intracellular - to-extracellular drug ratio:
A½ iþ AH½ i
A½ eþ AH½ e
¼ 1þ 10
pHipKað Þ
1þ 10 pHepKað Þ ð2Þ
Equation 1 predicts that alkalinization of tumor pHe will
increase weak base uptake into tumor cells, whereas
Equation 2 predicts that acidification of tumor pHe will
increase weak acid uptake into tumor cells. However,
concomitant alkalinization (or acidification) of normal tissue
pHe in the host animal would drive more drug into those
tissues as well. We have made pH measurements in both
tumor and hind leg to calculate the relative change in drug
uptake into tumors. For the pHe and pHi values observed in
tumor and normal (hind leg) tissue before and 2 hours after
alkalinization by i.p. administration of NaHCO3 (Figure 3B
and inset in Figure 2 ), we predict from Equation 1 that the
partitioning of mitoxantrone will increase by 1.5- fold in
normal tissue and five- fold in tumor tissue, and this is
depicted in Figure 6. Thus, a net therapeutic gain of 3.3- fold
is predicted when chemotherapy with mitoxantrone is
preceded by NaHCO3- induced alkalinization of the host
animal. Calculations for a hypothetical weak acid with pKa
6.0 predict that the acidosis induced by gavage adminis-
tration of NH4Cl (Figures 4 and 5 ) will drive two- fold more
drug into cells of hind leg tissue, but only 1.2- fold more drug
into cells in the tumor (Figure 6 ). Thus, acidosis induced in
the host animal by NH4Cl gavage may actually reduce the
effectiveness of a weak acid drug. Of course, drug dosage is
usually limited by cardiac and bone-marrow toxicities and
not toxicity to muscle, but reliable MRS measurements of
pHe in these organs could not be obtained. Tumor acid-
ification by gavage administration of NH4Cl appears to be not
tumor-selective and will not result in any gain in therapeutic
index for treatment with weak acid drugs. Kuin et al. [13]
report that induction of moderate degrees of hyperglycemia
combined with i.p. administration of m - iodobenzylguanidine
(MIBG), an inhibitor of mitochondrial respiration, lowers
tumor pHe but not pHi in RIF-1 tumors in C3H mice. Their
protocol seeks to enhance the degree of aerobic glycolysis
exhibited by tumor cells and may offer greater potential to
selectively acidify tumors.
The influence of NaHCO3- induced acute metabolic
alkalosis itself on tumor growth, as well as on tumor
response to mitoxantrone therapy, are shown in Figure
7A C. In an initial experiment, a group of four mice bearing
C3H tumors that were 200 to 300 mm3 in volume was
administered a single i.p. injection of 0.7 ml1 M NaHCO3
and denied access to ad libitum water for the following 4
hours. The mean tumor volumes of the NaHCO3-treated
group and an untreated control group are compared in Figure
7A. No significant change in tumor growth rates were
observed as a result of the NaHCO3 treatment. To test the
influence of NaHCO3- induced alkalosis on tumor response
to mitoxantrone therapy, four groups of four C3H tumor-
bearing mice each were treated with either two doses of 6
mg/kg mitoxantrone (groups A and B) or a single dose of 12
mg/kg mitoxantrone (groups C and D). Groups B and D
were also administered 0.7 ml1 M NaHCO3 ( i.p. ) 2 hours
before each mitoxantrone injection. The kinetics of tumor
alkalinization observed in Figure 3B  D indicate that
significant tumor alkalinization occurs a minimum of 2 hours
following NaHCO3 administration, and this was the reason
for the delay of 2 hours between NaHCO3 and mitoxantrone
injections administered to groups B and D. When the two
doses of 6 mg/kg were administered 4 days apart to
NaHCO3-treated mice, a significant enhancement of tumor
response to mitoxantrone was observed, but this was
accompanied by substantial loss of body weight in the mice
and increased rates of mortality compared to mice treated
with mitoxantrone alone (data not shown). Intraperitoneal
Figure 6. Theoretically calculated tissue–blood drug partition ratios: (A ) from
Equation 1, for combined NaHCO3 ( i.p. ) and mitoxantrone therapy, and (B )
from Equation 2, for combined therapy using NH4Cl ( gavage ) and a
hypothetical singly charged weak acid drug of pKa=6.0. For mitoxantrone a
pKa2 of 12 was assumed, because Equation 1 is insensitive to pKa2 for
physiological values of pHi and pHe. The following representative values of
pHe and pHi in control /NaHCO3 - treated /NH4Cl - treated animals, respec-
tively, were obtained from the data reported in Figures 2 –5 — tumor pHi
7.05 / 7.3 / 6.7, tumor pHe 6.7 / 7.3 / 6.16, hind leg pHi 7.33 / 7.5 / 7.15, and hind
leg pHe 7.35 /7.6 / 6.8 — and inserted into Equations 1 and 2 to obtain the
drug partition ratios shown here. Pretreatment with NaHCO3 ( i.p. ) is predicted
to result in a five - fold enhancement in uptake of mitoxantrone into tumor
tissue compared to tumor tissue in an untreated host, but only a 1.5 - fold
increase in uptake of drug into normal tissue in the NaHCO3 - treated animal
compared with normal tissue in an untreated animal. Thus, the chemo-
therapeutic index of mitoxantrone can potentially be increased 3.3 - fold by
NaHCO3 pretreatment of the host animal. However, acidosis induced by
gavage administration of NH4Cl to the host animal is not tumor specific,
resulting in a two - fold increase in uptake of a weak acid drug of pKa 6 into
normal tissue and only a 1.2 - fold increase in uptake into tumor tissue. Thus,
the chemotherapeutic index of a weak acid drug is predicted to be reduced by
gavage administration of NH4Cl.
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administration of NaHCO3 did not, however, alter the LD50 of
mitoxantrone when it was administered as a single dose
(data not shown). A gap of 7 days between successive
doses of 6 mg/kg mitoxantrone was well tolerated by
NaHCO3-treated mice, and this was used in subsequent
experiments. Figure 7B shows the tumor growth curves of
mice in groups A and B. The arrows in Figure 7B and C
indicate the days of treatment. The error bars (standard
deviation) in Figure 7B and C reflect not just the hetero-
geneity in response to treatment within each group, but also
the pretreatment heterogeneity in tumor volumes within each
treatment group. No deaths were recorded in any of the 4
groups during the course of the experiment. A tumor growth
delay (TGD) of 9 days was calculated for group A, whereas a
TGD of 15 days was calculated for tumors in NaHCO3-
treated mice from group B (Figure 7B ). Group C mice were
treated with a single 12 mg/kg dose of mitoxantrone
resulting in a TGD of 9 days, whereas a TGD of 16 days
was calculated for the mice in group D that were cotreated
with 12 mg/kg mitoxantrone and NaHCO3 (Figure 7C ).
Thus, cotreatment with NaHCO3 produced a significant
enhancement of TGD following mitoxantrone therapy when it
was given either as a single dose or as two fractionated
doses separated by 7 days. A comparison of the TGDs
shown in Figure 7B and C indicates that the TGD induced by
mitoxantrone therapy is not significantly altered by dose
fractionation, regardless of whether the therapy also
included NaHCO3 treatment or not. Log10 cell kills [14] were
calculated for groups C and D: mitoxantrone therapy in the
absence of NaHCO3 produced a 0.9 log10 cell kill, whereas
combined NaHCO3–mitoxantrone therapy results in a log10
cell kill of 1.56, indicating a greater than 4.5- fold increase in
cell kill effected by treatment with NaHCO3 before treatment
with mitoxantrone in this tumor model.
Discussion
Previously, we have reported that chronic supplementation
of ad libitum water provided to MCF-7 tumor-bearing SCID
mice with 200 mMNaHCO3 resulted in alkalinization of tumor
pHe by 0.8 pH units whereas increasing tumor pHi by only 0.2
pH units [9 ]. Chronic sodium bicarbonate therapy is
undesirable because it presents a substantial sodium load
to the animal, and is also impractical from the standpoint of
translation of this protocol to humans. Acute administration
of NaHCO3 by the oral and intravenous routes have been
reported to cause a small but significant increase in blood pH
in humans [15,16], although measurements of tissue pH in
humans following NaHCO3 administration are not found in
the literature. In our C3H tumor model, i.p. administration of
2.3 to 2.9 g/kg NaHCO3 to tumor-bearing C3Hmice resulted
in increases of 0.4 to 0.6 pH units in tumor pHe and 0.1 to
0.25 pH units in tumor pHi for periods of more than 3 to 6
hours, with only small changes in pHe and pHi of control
normal hind leg tissue. Theoretical calculations of mitoxan-
trone uptake into cells at these measured pHe and pHi values
indicate that a gain in therapeutic index of up to 3.3- fold is
possible with NaHCO3 pretreatment. Treatment of C3H
Figure 7. Growth curves for C3H tumors in (A ) untreated mice and NaHCO3
(0.7 ml1 M, i.p. ) - treated mice; (B ) mitoxantrone (6 mg / kg2 ) - treated
mice and mitoxantrone (6 mg / kg2 ) plus NaHCO3 (0.7 ml1 M2, i.p. ) -
treated mice; (C ) mitoxantrone (12 mg / kg ) - treated mice and mitoxantrone
(12 mg /kg ) plus NaHCO3 (0.7 ml1 M, i.p. ) - treated mice. Each point in
panels A to C represents the mean tumor volume from cohorts of four mice per
treatment group. Error bars in panels B and C represent standard deviations.
NaHCO3 treatment alone was found to not affect the growth rate of C3H
tumors ( panel A ). Treatment with mitoxantrone alone resulted in a TGD of 9
days, regardless of whether the 12 mg / kg dose was fractionated into two
doses (panel B ) or given as a single bolus ( panel C ). Combined treatment
with mitoxantrone and NaHCO3 resulted in a TGD of 15 to 16 days, regardless
of dose fractionation. Pretreatment with NaHCO3 resulted in an increase in
log10 cell kill from 0.9 to 1.56, corresponding to a greater than 4.5 - fold
increase in cell kill.
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tumors with 12 mg/kg mitoxantrone results in a log10 cell kill
of 0.9, whereas combined NaHCO3–mitoxantrone therapy
results in a log10 cell kill of 1.56. Kozin and Gerweck [17]
have shown that acid-adapted Chinese hamster ovary
(CHO) cells cultured at pH 6.8 maintain a pHi similar to that
of normal CHO cells cultured at pH 7.4. Acid-adapted CHO
cells were found to be 14- fold more resistant to mitoxantrone
than normal CHO cells. Theoretical calculations predict that
the increased (pHipHe) gradient in acid-adapted CHO
cells will result in a two- fold decrease in cellular mitoxan-
trone uptake, which is significantly less than the 14- fold
reduction in mitoxantrone toxicity to these cells, suggesting
that other pH-sensitive mechanisms also play a role in
potentiating mitoxantrone action on these cells. Thus, in our
in vivo experiments, although increased uptake of mitoxan-
trone by tumor cells in NaHCO3-treated mice due to
elimination of the acid-outside plasmalemmal pH gradient
would appear to be the primary mechanism by which tumor
response to mitoxantrone is enhanced, other explanations
cannot be ruled out. In our protocol, treatment with hyper-
osmolal NaHCO3 was accompanied by denial of ad libitum
water to the mice for 4 hours and this could conceivably have
reduced renal /biliary clearance of mitoxantrone from the
mice, thereby increasing drug retention in the entire animal.
This possible mechanism is currently under investigation. An
alternate explanation for the pH dependencies of the
toxicities of various ionic and nonionic drugs to tumor cells
has been proposed by Vukovic and Tannock [18]. They have
observed that a lower proportion of cells with acidic pHi are in
G1 phase than at alkaline pHi, leading to diminished
sensitivity to the drugs mitoxantrone (a weak base) and
paclitaxel (a zwitterion) in acidic cells [18]. In our experi-
ments, NaHCO3 treatment increased not only tumor pHe, but
also tumor pHi. Tumor pHe measurements using MRS
imaging (MRSI) reveal a heterogeneity in pHe [19] that
might conceivably lead to heterogeneity in tumor pHi as well.
Thus, although the volume-averaged pHi values in Figure
3B  D range from 6.75 to 7.05, there might exist pockets of
cells in these tumors that chronically experience even lower
pHi. Cells in such pockets may be quiescent, making them
resistant to antimitotic therapies, and alkalinization using
NaHCO3may bring them into G1 phase and sensitize them to
drug bound to their DNA. In this context, it is relevant to note
that although free mitoxantrone disappears from the blood in
mice within 1 hour of intravenous administration, drug has
been reported to remain bound to intracellular targets
beyond 48 hours [20]. For such a cell cycle–related
mechanism of drug enhancement to be active, tumor pHe
would need to remain higher than normal for several hours
following NaHCO3 administration. We have observed that
anesthetized mice remain alkalotic for at least up to 6 hours
following NaHCO3 administration. The kinetics of recovery
from NaHCO3 loading are likely different in alert mice, but
some effects of the NaHCO3 are present even 24 hours later:
we have observed that 24 hours following a single i.p. dose of
NaHCO3, mice exhibit delayed recovery from the ketamine/
xylazine/acepromazine anesthetic compared with untreated
control mice. We have not made pH measurements on mice
24 hours after NaHCO3 administration, but if tissue
alkalinization does indeed persist out to 24 h, this may be
long enough to cause quiescent tumor cells to re-enter G1
phase and become susceptible to bound drug that may have
been administered 24 hours earlier. Acute treatment with
NaHCO3 did not, however, alter the tumor growth rate in this
model.
In conclusion, oral administration of NH4Cl resulted in a
significant acidification of both pHe and pHi in tumors as well
as in control hind leg tissue in C3H mice. Theoretical
calculations of weak acid drug partitioning into tumor and
normal tissue cells show that the non–tumor-specific nature
of NH4Cl - induced acidosis may actually reduce the chemo-
therapeutic index of a weak acid drug. However, pretreat-
ment of tumor-bearing mice with NaHCO3 results in a
significant enhancement of tumor response to mitoxantrone,
although the exact mechanism by which this occurs remains
to be elucidated. Also requiring further investigation is the
mechanism of increased toxicity of mitoxantrone to
NaHCO3-treated C3H mice when the drug is administered
as two doses of 6 mg/kg given 4 days apart. This increased
toxicity to NaHCO3-treated mice, vis-a-vismice treated with
mitoxantrone alone, was not observed when the two doses of
6 mg/kg mitoxantrone were separated by 7 days, or when
the drug was administered as a single dose of 12 mg/kg.
Intraperitoneally administered NaHCO3 did not alter the LD50
of mitoxantrone to C3H mice when it was administered as a
single dose. Metabolic alkalosis can be induced in humans
as well, and small increases in blood pH have been reported
following oral administration of NaHCO3 [16], intravenous
NaHCO3 [15], intravenous Carbicarb (an equimolar mix of
Na2CO3 and NaHCO3) [15], and oral administration of the
loop diuretic furosemide [21]. Additionally, oral administra-
tion of NaHCO3 [22] or the carbonic anhydrase inhibitor
acetazolamide [23] has also been reported to achieve
significant alkalinization of urine in humans, and this may be
exploited for enhancement of therapies of certain bladder
and renal tumors that are treated using drug cocktails
containing vinca and anthracycline weak base drugs [12].
Techniques such as MRS and MRSI make it possible to
measure tissue pH noninvasively, allowing for a determi-
nation of the effects of agents like NaHCO3, carbicarb and
furosemide on tumor pH in humans. Demonstrable tumor-
selective alkalinization by one or more of these agents may
permit their use in humans to enhance tumor response to
weak base drugs.
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